Article Information
History
- January 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Nikhil Shri Sahajpal1,
- Ashis K Mondal1,
- Sudha Ananth1,
- Daniel Saul2,
- Soheil Shams2,
- Alex R Hastie2,
- Natasha M. Savage1,
- Vamsi Kota3,
- Alka Chaubey2 and
- Ravindra Kolhe1,*
- 1Department of Pathology, Medical College of Georgia, Augusta University, GA, 30912, USA
- 2Bionano Genomics Inc., San Diego, CA 92121, USA
- 3Department of Medicine and Georgia Cancer Center, Medical College of Georgia, Augusta University, GA, 30912, USA
- ↵*Corresponding author Ravindra Kolhe MD, PhD., Medical College of Georgia| Augusta University., BAE 2576, 1120 15th Street| Augusta, GA 30912, Email: rkolhe{at}augusta.edu, P: (706)-721-2771
Posted January 17, 2022.
Clinical Utility of Combined Optical Genome Mapping and 523-gene Next Generation Sequencing Panel For Comprehensive Evaluation of Myeloid Cancers
